Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:46 PM
Study NCT ID:
NCT01598051
Status:
COMPLETED
Last Update Posted:
2019-05-30
First Post:
2012-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-20
First Submit QC Date:
None
Study First Post Date:
2012-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-28
Last Update Post Date:
2019-05-30
Last Update Post Date Type:
ACTUAL